Shanghai Shen Lian Biomedical Corporation announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 153.028 million compared to CNY 154.617 million a year ago. Operating income was CNY 50.083 million compared to CNY 67.325 million a year ago. Net income was CNY 44.421 million compared to CNY 60.751 million a year ago. Basic earnings per share from continuing operations was CNY 0.11 compared to CNY 0.15 a year ago.